Patents Represented by Attorney, Agent or Law Firm Daniel W. Collins
  • Patent number: 4673763
    Abstract: Procainamide and N-acetylprocainamide (NAPA) immunogens, antibodies prepared therefrom, labeled conjugates, synthetic intermediates, and the use of such antibodies and labeled conjugates in immunoassays for determining the respective drugs. The immunogens comprise the drugs coupled at the .alpha.-position of the amide side chain to an immunogenic carrier material. The labeled conjugates and synthetic intermediates similarly are .alpha.-position derivatives of the drugs or precursors thereof. The antibodies and labeled conjugates are particularly useful in homogeneous nonradioisotopic immunoassays for measuring the respective drugs in biological fluids such as serum.
    Type: Grant
    Filed: March 18, 1985
    Date of Patent: June 16, 1987
    Assignee: Miles Laboratories, Inc.
    Inventors: Robert T. Buckler, Frederick E. Ward
  • Patent number: 4650771
    Abstract: Immunogens for preparing antibodies against the drug lidocaine and related compounds, labeled conjugates, synthetic intermediates, and the use of such antibodies and labeled conjugates in immunoassays for determining lidocaine and such related compounds. The immunogens comprise lidocaine or an analog thereof coupled through one of the aromatic methyl groups to a conventional immunogenic carrier. The antibodies and labeled conjugates are particularly useful in homogeneous nonradioisotopic immunoassays for measuring lidocaine or its analogs in biological fluids such as serum.
    Type: Grant
    Filed: November 4, 1983
    Date of Patent: March 17, 1987
    Assignee: Miles Laboratories, Inc.
    Inventors: Robert T. Buckler, John F. Burd, Stephan G. Thompson
  • Patent number: 4647668
    Abstract: Disopyramide immunogens, antibodies prepared therefrom, labeled conjugates, synthetic intermediates, and the use of such antibodies and labeled conjugates in immunoassays for determining disopyramide. The immunogens comprise disopyramide coupled by an ether linkage at a selected singular position on its phenyl ring to an immunogenic carrier material. Likewise, the labeled conjugates and synthetic intermediates are phenyl ether derivatives of disopyramide or precursors thereof. The antibody and labeled conjugates are particularly useful in homogeneous nonradioisotopic immunoassays for measuring disopyramide in biological fluids such as serum.
    Type: Grant
    Filed: May 20, 1985
    Date of Patent: March 3, 1987
    Assignee: Miles Laboratories, Inc.
    Inventors: Robert T. Buckler, Stephan G. Thompson